Add to MyYahoo RSS

Biotech News

Biotech news continually updated from thousands of sources around the net.

30 min ago | USA Today

Got a spider bite? Most of the time no need to panic

An increase in spider-bite patients at Vanderbilt University Medical Center here has created some concern - but not about an influx of brown recluse spiders in garages or bathroom cabinets.


Related Topix: Vanderbilt University, Centers for Disease Control and Prevention, Medicine, Healthcare Industry, Illinois, Entomology, Science

3 hrs ago | The Independent

Broken up? GlaxoSmithKline's real problem is getting eaten up by scandal

Note: We do not store your email address but your IP address will be logged to prevent abuse of this feature.


Related Topix: GlaxoSmithKline, US News

6 hrs ago | USA Today

Pay up! The companies charging you more

Inflation is mild? That's what the government says, but investors paying attention to earnings calls are hearing something they haven't heard in a awhile: Some bold companies are raising prices.


Related Topix: Philip Morris International, Tobacco, Allergan

10 hrs ago | Seeking Alpha

Investment Advice From The Federal Reserve: Unusual, Unwise And Unseemly

On July 15, Janet Yellen made news with her semiannual policy testimony to Congress, with her views on interest rates, bubbles and the debt market.


Related Topix: Financial Markets, Science / Technology, Startups, Facebook, Advertising

14 hrs ago | West Australian

Pfizer's need for deal looms larger with earnings report

While many industry watchers expect Pfizer to re-engage with Britain's AstraZeneca in coming months, some say the U.S. drugmaker should consider targets more focussed on biotechnology, a strategy that has paid off for Merck & Co Although Pfizer is conducting trials of promising products - including breast cancer drug palbociclib and vaccines ... (more)


Related Topix: Merck , Medicine, Healthcare Industry, Health, Breast Cancer, Cancer

Sun Jul 27, 2014

DNA India

Wockhardt's plant may soon get out of regulatory woes

Wockhardt Ltd, which denied stake-sale rumours on Friday following an unusual spurt in its stock price, is in the final stages of receiving much-awaited regulatory approvals for its Chikalthana unit in Maharashtra.


Related Topix: Wockhardt, Food and Drug Administration, World News, India,

The Olympian

How will we pay for a $300,000 drug?

Developed by Vertex Pharmaceuticals, it is the first drug that attacks not just the symptoms but the underlying cause of cystic fibrosis, a genetic lung disease that usually kills victims by the time they reach their 40s.


Related Topix: Vertex, Vertex Pharmaceuticals, Medicine, Healthcare Industry, Cystic Fibrosis, Health, Fibrosis, Genetics, Healthcare Law, Law

KVBC-TV Las Vegas

Trial in salmonella outbreak to start in Georgia

Three people accused of scheming to manufacture and ship salmonella-tainted peanuts that killed nine people and sickened more than 700 are set to go to trial this week in Georgia.


Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry

Kenya Broadcasting Corporation

Merck introduces e-learning courses for medical students, professionals

Merck has kicked off its second year of its five year project to provide European Accredited Clinical Diabetes Management course for medical and pharmacy students in African Universities by introducing E-Learning.


Related Topix: Merck , Medicine, Healthcare Industry

New Scientist

Genetic moderation is needed to debate our food future

GM is now a term loaded with baggage. Scientists must allow for people's objections to show the public there's nothing "spooky" about it WITH food security firmly on the international agenda, there's a growing appetite to look again at the opportunities promised by agricultural biotechnology.


Related Topix: Genetics, Medicine, Agriculture, Science, Science / Technology

News Observer

Summer of sequencing genomes

The second, accepted but not yet published by Theoretical and Applied Genetics, was done with several of the professional scientists mentoring the P2EP interns.


Related Topix: Genetics, Medicine, Biology, Science, Winston-Salem, NC, Science / Technology, Bioinformatics

Sat Jul 26, 2014

Medical News

EGPAF applauds new licensing agreement to improve access to HIV medication for children

The Elizabeth Glaser Pediatric AIDS Foundation applauds the new licensing agreement between the Medicines Patent Pool and Gilead Sciences, Inc. to improve access to tenofovir alafenamide fumarate , a promising new HIV medication.


Related Topix: HIV/AIDS, Health, Medicine, Gilead Sciences, Healthcare Industry, Australia, World News,

WTVG-TV Toledo

Lou Gehrig's disease is rare, 1st US count finds

The government has issued its first national estimate for Lou Gehrig's disease, confirming the devastating disease is rare.


Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry

The Globe and Mail

Why Janet Yellen is wrong about biotech and social media

In this , Tuesday, Feb. 11, 2014, file photo, Federal Reserve Chair Janet Yellen listens while testifying on Capitol Hill in Washington.


Related Topix: Science / Technology, Financial Markets

Merck to cut 600 jobs at Montgomery County facilities

Merck & Co., which is reorganizing to slash $2.5 billion in costs and 8,500 workers, has informed Pennsylvania officials that it will cut 600 jobs at facilities in North Wales and Lansdale.


Related Topix: Merck , Medicine, Healthcare Industry, Montgomery County, PA, Merck & Co., North Wales, PA, Lansdale, PA, Law, Employment / Labor Law

The Washington Post

Puma's Auerbach Gains on Pfizer Retreat From Breast Cancer Drug

Alan Auerbach specializes in testing drugs that Big Pharma doesn't want anymore, and that has made him a billionaire.


Related Topix: Pfizer, Medicine, Healthcare Industry, Health, Breast Cancer, Science / Technology, Healthcare Law, Law, Johnson and Johnson Merck Consumer Pharmaceuticals

Fri Jul 25, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

Le CMUH europen adopte une opinion positive envers le Zydelig de Gilead pour le traitement de la leucmie lymphode chronique et du lymphome folliculaire )--Gilead Sciences, Inc. a annoncA© aujourd'hui que le ComitA© des mA©dicaments A usage humain , le comitA© scientifique de l'Agence europA©e... )--Gilead Sciences, Inc.


Related Topix: Medicine, Gilead Sciences, Healthcare Industry, Startups, Food and Drug Administration

Business Journal

My tour of Millennium Pharmaceuticals' imaging lab for mice

"Our patients are predominently mice." That's how the conversation began with Daniel Bradley, the associate director at Takeda Pharmaceuticals International Co.


Related Topix: Medicine, Millennium Pharmaceuticals, Healthcare Industry


Novo wins EU recommendation for two-in-one diabetes drug

A Novo Nordisk drug combining its long-acting insulin degludec with its type 2 diabetes treatment Victoza has been recommended for approval in Europe, in an important boost for the Danish company.


Related Topix: Medicine, Health, Diabetes, Novo Nordisk AS, Insulin (generic), Humulin, Novolin

AbbVie 2Q profit climbs 2.8 percent

Drugmaker AbbVie Inc.'s second-quarter profit increased nearly 3 percent and beat analysts' expectations, as sales soared for the world's top-selling drug, Humira.


Related Topix: North Chicago, IL, Shire plc


Biotech Jobs